Cargando…

Clinically available RNA profiling tests of prostate tumors: utility and comparison

In the postscreening era, physicians are in need of methods to discriminate aggressive from nonaggressive prostate cancer (PCa) to reduce overdiagnosis and overtreatment. However, studies have shown that prognoses (e.g., progression and mortality) differ even among individuals with similar clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Na, Rong, Wu, Yishuo, Ding, Qiang, Xu, Jianfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4955181/
https://www.ncbi.nlm.nih.gov/pubmed/26975490
http://dx.doi.org/10.4103/1008-682X.175096

Ejemplares similares